E-submission
THE KOREAN LIVER CANCER ASSOCIATION
Search
- Page Path
- HOME > Search
Review Article
- Ras Mitogen-activated Protein Kinase Signaling and Kinase Suppressor of Ras as Therapeutic Targets for Hepatocellular Carcinoma
- Hyuk Moon, Simon Weonsang Ro
- J Liver Cancer. 2021;21(1):1-11. Published online March 31, 2021
- DOI: https://doi.org/10.17998/jlc.21.1.1
- 6,307 Views
- 220 Downloads
- 4 Citations
-
Abstract
PDF - Hepatocellular carcinoma (HCC) is a high incidence cancer and a major health concern worldwide. Among the many molecular signaling pathways that are dysregulated in HCC, the Ras mitogen-activated protein kinase (Ras/Raf/MAPK) signaling pathway has gained renewed attention from basic and clinical researchers. Mutations in Ras and Raf genes which are known to activate the Ras/Raf/MAPK signaling pathway have been infrequently detected in human HCC; however, the Ras/Raf/MAPK signaling pathway is activated in more than 50% of HCC cases, suggesting an alternative mechanism for the activation of the signaling pathway. Kinase suppressor of Ras acts as a molecular scaffold for facilitating the assembly of Ras/Raf/MAPK signaling pathway components and has been implicated in the regulation of this signaling pathway. In this review, we provide important insights into the cellular and molecular mechanisms involved in the activation of the Ras/Raf/MAPK signaling pathway and discuss potential therapeutic strategies for HCC.
-
Citations
Citations to this article as recorded by
- Lipid‐lowering activity and underlying mechanism of glycosylated peptide–calcium chelate prepared by transglutaminase pathway
Xiaoping Wu, Xu Chen, Xixi Cai, Shaoyun Wang
Food Frontiers.2024; 5(1): 160. CrossRef - CT-guided high dose rate brachytherapy can induce multiple systemic proteins of proliferation and angiogenesis predicting outcome in HCC
Lukas Salvermoser, Shraga Nahum Goldberg, Marianna Alunni-Fabbroni, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Jan Niklas Schäfer, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Agnese Petrera, Moritz Wildgruber, Jens Ricke,
Translational Oncology.2024; 43: 101919. CrossRef - Network-Pharmacology-Based Study on Active Phytochemicals and Molecular Mechanism of Cnidium monnieri in Treating Hepatocellular Carcinoma
Shakeel Ahmad Khan, Terence Kin Wah Lee
International Journal of Molecular Sciences.2022; 23(10): 5400. CrossRef - Identification of potential target genes of honokiol in overcoming breast cancer resistance to tamoxifen
Adam Hermawan, Herwandhani Putri, Naufa Hanif, Nurul Fatimah, Heri Himawan Prasetio
Frontiers in Oncology.2022;[Epub] CrossRef
- Lipid‐lowering activity and underlying mechanism of glycosylated peptide–calcium chelate prepared by transglutaminase pathway
First
Prev
Follow JLC on Twitter